Please login to the form below

Not currently logged in
Email:
Password:

Simon Grime joins Fendix Media as commercial director

Moves to the online network of NHS websites from M3

Simon Grime joins Fendix Media as commercial directorFendix Media has appointed Simon Grime as its new commercial director, handing him responsibility for driving the growth of its network of NHS websites.

The Nottinghamshire, UK-based company enables pharma companies and firms from other sectors to use NHS intranets and websites as messaging platforms.

Grime joins Fendix from M3, the owner of the UK's largest online network of doctors Doctors.net.uk, where he served for three years as managing director of its communications business.

He said: “These are exciting times in the digital healthcare landscape and for Fendix Media, and I am very much looking forward to helping the company to capitalise on its unique offering for organisations that want to reach HCPs through one of their most trusted and frequently used channels.”

In Grime's new role his tasks will also include leading the introduction of new advertising products for pharma and other organisations to utilise within the NHS intranets used daily by staff at NHS trusts.

Simon Feeney, director and co-founder of Fendix Media, said: “We're delighted to welcome Simon Grime to our company. He has significant experience in the digital media industry and, in particular, across the healthcare landscape. We look forward to working with him and growing the business from strength to strength."

9th July 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...